Neuronal M 3 muscarinic acetylcholine receptors are essential for somatotroph proliferation and normal somatic growth

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 15, 2009, Pages 6398-6403

  Gautam, Dinesh ^a   Jeon, Jongrye ^a   Starost, Matthew F ^b   Han, Sung Jun ^a,e   Hamdan, Fadi F ^a,f   Cui, Yinghong ^a   Parlow, Albert F ^c   Gavrilova, Oksana ^a   Szalayova, Ildiko ^d   Mezey, Eva ^d   Wess, Jürgen ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^e Institute Pasteur Korea   (South Korea)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Anterior pituitary gland; Dwarfism; Knockout mice

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYPOTHALAMUS HORMONE; MUSCARINIC M3 RECEPTOR; PROLACTIN; MESSENGER RNA; MUSCARINIC RECEPTOR; SOMATOMEDIN C;

ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DWARFISM; FEMALE; GLIA CELL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE SECRETING CELL; HORMONE DETERMINATION; HYPOPLASIA; MALE; MOUSE; MUTANT; NERVE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN LOCALIZATION; ANIMAL; BLOOD; BODY WEIGHT; BRAIN; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT;

MUS;

ANIMALS; BODY WEIGHT; BRAIN; CELL PROLIFERATION; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, KNOCKOUT; RECEPTORS, MUSCARINIC; RNA, MESSENGER; SOMATOTROPHS;

EID: 65549124473     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0900977106     Document Type: Article

References (43)

1. Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797.
2. Locatelli V, et al. (1986) Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: Evidence for mediation by somatostatin. J Endocrinol 111:271-278.
3. Torsello A, et al. (1988) Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat. J Endocrinol 117:273-281.
4. Arce VM, Cella SG, Locatelli V, Mü ller EE (1991) Studies of growth hormone secretion in calorically restricted dogs: Effect of cholinergic agonists and antagonists, glucose and thyrotropin-releasing hormone. Neuroendocrinology 53:467-472.
5. Delitala G, et al. (1983) Cholinergic receptor control mechanisms for L-dopa, apomor-phine, and clonidine-induced growth hormone secretion in man. J Clin Endocrinol Metab 57:1145-1149.
6. Casanueva FF, Villanueva L, Cabranes JA, Cabezas-Cerrato J, Fernandez-Cruz A (1984) Cholinergic mediation of growth hormone secretion elicited by arginine, clonidine, and physical exercise in man. J Clin Endocrinol Metab 59:526-530.
7. Taylor BJ, Smith PJ, Brook CG (1985) Inhibition of physiological growth hormone secretion by atropine. Clin Endocrinol (Oxford) 22:497-501.
8. Massara F, et al. (1986) Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: Studies in normal and acromegalic subjects. Neuroendocrinology 43:670-675.
9. Peters JR, et al. (1986) Cholinergic muscarinic receptor blockade with pirenzepine abolishes slow wave sleep-related growth hormone release in normal adult males. Clin Endocrinol (Oxford) 25:213-217.
10. Wess J (1996) Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neu-robiol 10:69-99.
11. Caulfield MP, Birdsall NJM (1998) International Union of Pharmacology. XVII. Classifi-cation of muscarinic acetylcholine receptors. Pharmacol Rev 50:279-290.
12. Levey AI (1993) Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 52:441-448.
13. Vilaro MT, Mengod G, Palacios JM (1993) Advances and limitations of the molecular neuroanatomy of cholinergic receptors: The example of multiple muscarinic receptors. Prog Brain Res 98:95-101.
14. Wolfe BB, Yasuda RP (1995) Development of selective antisera for muscarinic cholin-ergic receptor subtypes. Ann NY Acad Sci 757:186-193.
15. Wess J, Eglen RM, Gautam D (2007) Muscarinic acetylcholine receptors: Mutant mice provide new insights for drug development. Nat Rev Drug Discov 6:721-733.
16. Levey AI, Edmunds SM, Heilman CJ, Desmond TJ, Frey KA (1994) Localization of muscarinic m3 receptor protein and M3 receptor binding in rat brain. Neuroscience 63:207-221.
17. Yamada M, et al. (2001) Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 410:207-212.
18. Oki T, et al. (2005) Quantitative analysis of binding parameters of [3H]N-methylsco-polamine in central nervous system of muscarinic acetylcholine receptor knockout mice. Mol Brain Res 133:6-11.
19. Jetté L, et al. (2005) Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: Identification of CJC-1295 as a long-lasting GRF analog. Endocrinology 146:3052-3058.
20. Alba M, et al. (2006) Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol 291:E1290-E1294.
21. Teichman SL, et al. (2006) Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab 91:799-805.
22. Gautam D, et al. (2000) A critical role for β cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 3:449-461.
23. Tronche F, et al. (1999) Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23:99-103.
24. Gautam D, et al. (2004) Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice. Mol Pharmacol 66:260-267.
25. Gautam D, et al. (2006) Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency. Cell Metab 4:363-375.
26. Sun Y, Wang P, Zheng H, Smith RG (2004) Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 101:4679-4684.
27. Yakar S, et al. (2002) Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781.
28. Nilsson O, Marino R, De Luca F, Phillip M, Baron J (2005) Endocrine regulation of the growth plate. Horm Res 64:157-165.
29. Lin SC, et al. (1993) Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 364:208-213.
30. Ostrom KM (1990) A review of the hormone prolactin during lactation. Prog Food Nutr Sci 14:1-43.
31. Cohen LE, Radovick S (2002) Molecular basis of combined pituitary hormone deficien-cies. Endocr Rev 23:431-442.
32. Wettschureck N, et al. (2005) Loss of Gq/11 family G proteins in the nervous system causes pituitary somatotroph hypoplasia and dwarfism in mice. Mol Cell Biol 25:1942-1948.
33. Frohman LA, Kineman RD (2002) Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis. Trends Endocrinol Metab 13:299-303.
34. Le Tissier PR, et al. (2005) Hypothalamic growth hormone-releasing hormone (GHRH) deficiency: Targeted ablation of GHRH neurons in mice using a viral ion channel transgene. Mol Endocrinol 19:1251-1262.
35. Suhr ST, Rahal JO, Mayo KE (1989) Mouse growth-hormone-releasing hormone: Precursor structure and expression in brain and placenta. Mol Endocrinol 3:1693-1700.
36. Baccam N, et al. (2007) Dual-level afferent control of growth hormone-releasing hormone (GHRH) neurons in GHRH-green fluorescent protein transgenic mice. J Neu-rosci 27:1631-1641.
37. Moore JP, Jr, et al. (2000) Pituitary hormone gene expression and secretion in human growth hormone-releasing hormone transgenic mice: Focus on lactotroph function. Endocrinology 141:81-90.
38. Alba M, Salvatori R (2004) A mouse with targeted ablation of the growth hormone-releasing hormone gene: A new model of isolated growth hormone deficiency. Endocrinology 145:4134-4143.
39. Li H, Zeitler PS, Valerius MT, Small K, Potter SS (1996) Gsh-1, an orphan Hox gene, is required for normal pituitary development. EMBO J 15:714-724.
40. Low MJ, et al. (2001) Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth. J Clin Invest 107:1571-1580.
41. Bossé R, et al. (1997) Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19:127-138.
42. Zimmerman L, et al. (1994) Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 12:11-24.
43. Alba M, Schally AV, Salvatori R (2005) Partial reversibility of growth hormone (GH) deficiency in the GH-releasing hormone (GHRH) knockout mouse by postnatal treatment with a GHRH analog. Endocrinology 146:1506-1513.